Rating History for Crescent Biopharma Inc (CBIO) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/28/2026 | Biren Amin | New Coverage | Overweight (N/A) |
N/A (N/A) |
11.75 (17.98) |
53.02% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/28/2026 | Biren Amin | New Coverage | Overweight (N/A) |
N/A (N/A) |
11.75 (17.98) |
53.02% | Details |
![]() |
|||||||